In our study, the analysis revealed that among the 381 patients with EGC who fully met the absolute indications for ESD, 28 patients had lymph node metastasis and 4 (14.3%) had a positive HER2 expression. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.